$64.2 Million is the total value of Mayo Clinic's 9 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 22.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BSM | Buy | Black Stone Minerals | $35,120,000 | -5.4% | 5,719,924 | +0.2% | 47.33% | +33.3% |
| ZNTL | Buy | Zentalis Pharmaceuticals Inc | $14,472,000 | -31.9% | 442,714 | +0.0% | 19.50% | -4.1% |
| SPY | Sell | SPDR ETF | $5,529,000 | -80.2% | 16,511 | -81.8% | 7.45% | -72.2% |
| UBX | Unity Biotechnology Inc | $5,439,000 | -60.1% | 1,571,981 | 0.0% | 7.33% | -43.9% | |
| BSGM | Sell | Biosig Tech Inc | $4,974,000 | +341.7% | 100,891 | -35.5% | 6.70% | +522.4% |
| EXAS | New | Exact Sciences Corp | $3,353,000 | – | 3,289 | +100.0% | 4.52% | – |
| CLPT | Clearpoint Neuro Inc (fka MRI INTERVENTIONS INC) | $2,574,000 | +1432.1% | 47,148 | 0.0% | 3.47% | +2054.7% | |
| EVLO | Evelo Bioseciences Inc | $2,556,000 | +7.6% | 484,953 | 0.0% | 3.44% | +51.6% | |
| CGIX | CANCER GENETICS INC | $184,000 | +18300.0% | 444 | 0.0% | 0.25% | +24700.0% | |
| MCRB | Exit | Seres Therapeutics Inc | $0 | – | -180,000 | -100.0% | -0.82% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BLACK STONE MINERALS | 11 | Q3 2023 | 82.2% |
| Evelo Bioseciences Inc | 11 | Q3 2023 | 7.3% |
| BIOSIG TECH INC | 10 | Q2 2023 | 6.7% |
| Clearpoint Neuro Inc (Frmly MRI INTERVENTIONS INC) | 10 | Q3 2023 | 3.5% |
| Zentalis Pharmaceuticals Inc | 9 | Q3 2023 | 22.6% |
| UNITY BIOTECHNOLOGY INC | 8 | Q4 2022 | 23.1% |
| EXACT SCIENCES CORP | 7 | Q2 2023 | 4.5% |
| Neuroon Medical Technologies | 5 | Q3 2023 | 1.3% |
| MSCI ACWI ETF | 4 | Q3 2023 | 89.6% |
| Sorrento Therapeutics | 4 | Q4 2022 | 6.1% |
View Mayo Clinic's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| VENTURE LENDING & LEASING IV INC | March 16, 2005 | 6,000 | 6.0% |
View Mayo Clinic's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-05-05 |
| 13F-HR/A | 2023-02-09 |
| 13F-HR | 2023-01-26 |
| 13F-HR | 2021-08-12 |
| 13F-HR | 2021-05-13 |
| 13F-HR | 2021-02-11 |
| 13F-HR | 2020-11-12 |
View Mayo Clinic's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.